GlassScriptPhysician profile
Gary P Lengel
NPI 1770523938
$1,383.86
in general payments reported to CMS, 2019-2025
12 companies · $36.18 in 2025
The $36.18 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $283 · 2021: $255 · 2022: $146 · 2023: $162 · 2024: $108 · 2025: $36.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $613.42 | 2019-2024 | Puraply |
| Smith+Nephew, INC. | $354.15 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Regranex |
| Tactile Systems Technology INC | $155.16 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Hydrofera LLC | $100.58 | 2023 | Hydrofera Blue |
| Convatec INC. | $34.79 | 2019-2022 | |
| Urgo Medical North America, LLC | $20.90 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Kci USA, INC. | $20.51 | 2019 | |
| Kerecis Limited | $20.15 | 2022 | |
| Abbvie INC. | $17.62 | 2023 | |
| Integra Lifesciences Corporation | $17.48 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.59 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Lengel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.